Literature DB >> 26611435

Embedding clinical interventions into observational studies.

Anne B Newman1, M Larissa Avilés-Santa2, Garnet Anderson3, Gerardo Heiss4, Wm James Howard5, Mitchell Krucoff6, Lewis H Kuller7, Cora E Lewis8, Jennifer G Robinson9, Herman Taylor10, Roberto P Treviño11, William Weintraub12.   

Abstract

Novel approaches to observational studies and clinical trials could improve the cost-effectiveness and speed of translation of research. Hybrid designs that combine elements of clinical trials with observational registries or cohort studies should be considered as part of a long-term strategy to transform clinical trials and epidemiology, adapting to the opportunities of big data and the challenges of constrained budgets. Important considerations include study aims, timing, breadth and depth of the existing infrastructure that can be leveraged, participant burden, likely participation rate and available sample size in the cohort, required sample size for the trial, and investigator expertise. Community engagement and stakeholder (including study participants) support are essential for these efforts to succeed.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Clinical trial; Cohort; Epidemiology; Hybrid design; Observational study

Mesh:

Year:  2015        PMID: 26611435      PMCID: PMC5626440          DOI: 10.1016/j.cct.2015.11.017

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  33 in total

1.  Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women).

Authors:  Connie N Hess; Sunil V Rao; David F Kong; Laura H Aberle; Kevin J Anstrom; C Michael Gibson; Ian C Gilchrist; Alice K Jacobs; Sanjit S Jolly; Roxana Mehran; John C Messenger; L Kristin Newby; Ron Waksman; Mitchell W Krucoff
Journal:  Am Heart J       Date:  2013-07-23       Impact factor: 4.749

2.  Cardiovascular disease among women residing in rural America: epidemiology, explanations, and challenges.

Authors:  Herman A Taylor; Gail D Hughes; Robert J Garrison
Journal:  Am J Public Health       Date:  2002-04       Impact factor: 9.308

3.  Early Phase Clinical Trials: Referral Barriers and Promoters among Physicians.

Authors:  Amelie G Ramirez; Patricia Chalela; Lucina Suarez; Edgar Muñoz; Brad H Pollock; Steven D Weitman; Kipling J Gallion
Journal:  J Community Med Health Educ       Date:  2012-09-24

4.  Recruitment and retention of African American and Hispanic girls and women in research.

Authors:  Debra C Wallace; Robin Bartlett
Journal:  Public Health Nurs       Date:  2012-11-22       Impact factor: 1.462

5.  Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.

Authors:  Ross L Prentice; Robert D Langer; Marcia L Stefanick; Barbara V Howard; Mary Pettinger; Garnet L Anderson; David Barad; J David Curb; Jane Kotchen; Lewis Kuller; Marian Limacher; Jean Wactawski-Wende
Journal:  Am J Epidemiol       Date:  2006-02-16       Impact factor: 4.897

6.  Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.

Authors:  Ross L Prentice; Rowan T Chlebowski; Marcia L Stefanick; Joann E Manson; Robert D Langer; Mary Pettinger; Susan L Hendrix; F Allan Hubbell; Charles Kooperberg; Lewis H Kuller; Dorothy S Lane; Anne McTiernan; Mary Jo O'Sullivan; Jacques E Rossouw; Garnet L Anderson
Journal:  Am J Epidemiol       Date:  2008-04-29       Impact factor: 4.897

7.  Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.

Authors:  Ross L Prentice; Rowan T Chlebowski; Marcia L Stefanick; Joann E Manson; Mary Pettinger; Susan L Hendrix; F Allan Hubbell; Charles Kooperberg; Lewis H Kuller; Dorothy S Lane; Anne McTiernan; Mary Jo O'Sullivan; Jacques E Rossouw; Garnet L Anderson
Journal:  Am J Epidemiol       Date:  2008-03-27       Impact factor: 4.897

8.  Developing improved observational methods for evaluating therapeutic effectiveness.

Authors:  R I Horwitz; C M Viscoli; J D Clemens; R T Sadock
Journal:  Am J Med       Date:  1990-11       Impact factor: 4.965

9.  Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.

Authors:  Barbara V Howard; Mary J Roman; Richard B Devereux; Jerome L Fleg; James M Galloway; Jeffrey A Henderson; Wm James Howard; Elisa T Lee; Mihriye Mete; Bryce Poolaw; Robert E Ratner; Marie Russell; Angela Silverman; Mario Stylianou; Jason G Umans; Wenyu Wang; Matthew R Weir; Neil J Weissman; Charlton Wilson; Fawn Yeh; Jianhui Zhu
Journal:  JAMA       Date:  2008-04-09       Impact factor: 56.272

Review 10.  Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines.

Authors:  R P Symonds; K Lord; A J Mitchell; D Raghavan
Journal:  Br J Cancer       Date:  2012-05-31       Impact factor: 7.640

View more
  6 in total

1.  Toward Establishing Core Outcome Domains For Trials in Kidney Transplantation: Report of the Standardized Outcomes in Nephrology-Kidney Transplantation Consensus Workshops.

Authors:  Allison Tong; John Gill; Klemens Budde; Lorna Marson; Peter P Reese; David Rosenbloom; Lionel Rostaing; Germaine Wong; Michelle A Josephson; Timothy L Pruett; Anthony N Warrens; Jonathan C Craig; Benedicte Sautenet; Nicole Evangelidis; Angelique F Ralph; Camilla S Hanson; Jenny I Shen; Kirsten Howard; Klemens Meyer; Ronald D Perrone; Daniel E Weiner; Samuel Fung; Maggie K M Ma; Caren Rose; Jessica Ryan; Ling-Xin Chen; Martin Howell; Nicholas Larkins; Siah Kim; Sobhana Thangaraju; Angela Ju; Jeremy R Chapman
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

2.  Multilevel Interventions Targeting Obesity: Research Recommendations for Vulnerable Populations.

Authors:  June Stevens; Charlotte Pratt; Josephine Boyington; Cheryl Nelson; Kimberly P Truesdale; Dianne S Ward; Leslie Lytle; Nancy E Sherwood; Thomas N Robinson; Shirley Moore; Shari Barkin; Ying Kuen Cheung; David M Murray
Journal:  Am J Prev Med       Date:  2016-10-26       Impact factor: 5.043

3.  The Multi-Ethnic Study of Atherosclerosis individual response to vitamin D trial: Building a randomized clinical trial into an observational cohort study.

Authors:  Ian H de Boer; David K Prince; Kayleen Williams; Norrina B Allen; Gregory L Burke; Andrew N Hoofnagle; Simon Hsu; Xiaohui Li; Kiang J Liu; Robyn L McClelland; Erin D Michos; Bruce M Psaty; Steven J Shea; Kenneth M Rice; Jerome I Rotter; David S Siscovick; Russell P Tracy; Karol E Watson; Bryan R Kestenbaum
Journal:  Contemp Clin Trials       Date:  2021-02-12       Impact factor: 2.226

Review 4.  Establishing core outcome sets for phenylketonuria (PKU) and medium-chain Acyl-CoA dehydrogenase (MCAD) deficiency in children: study protocol for systematic reviews and Delphi surveys.

Authors:  Beth K Potter; Brian Hutton; Tammy J Clifford; Nicole Pallone; Maureen Smith; Sylvia Stockler; Pranesh Chakraborty; Pauline Barbeau; Chantelle M Garritty; Michael Pugliese; Alvi Rahman; Becky Skidmore; Laure Tessier; Kylie Tingley; Doug Coyle; Cheryl R Greenberg; Lawrence Korngut; Alex MacKenzie; John J Mitchell; Stuart Nicholls; Martin Offringa; Andreas Schulze; Monica Taljaard
Journal:  Trials       Date:  2017-12-19       Impact factor: 2.279

Review 5.  Developments in evidence creation for treatments of inborn errors of metabolism.

Authors:  Sylvia Stockler-Ipsiroglu; Beth K Potter; Nataliya Yuskiv; Kylie Tingley; Marc Patterson; Clara van Karnebeek
Journal:  J Inherit Metab Dis       Date:  2020-10-04       Impact factor: 4.982

6.  Natural or Urban Campus Walks and Vitality in University Students: Exploratory Qualitative Findings from a Pilot Randomised Controlled Study.

Authors:  Topaz Shrestha; Zelda Di Blasi; Marica Cassarino
Journal:  Int J Environ Res Public Health       Date:  2021-02-19       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.